FDA clears IND for ADI-212, an off-the-shelf PSMA-targeted gamma-delta CAR T for metastatic castration-resistant prostate ...

Rarely has a footnote garnered so much positive attention, but a reference in the newly updated prostate cancer guidelines from the National Comprehensive Cancer Network (NCCN) has prostate cancer ...

USA: Researchers have found in a study of 112 patients that Ga-68 PSMA-11 PET/CT detected and localized recurrent prostate ...

Competitors described in a tabular format covering drug code/INN, target(s)/MoA, class of compound, product category, indication(s) & R&D stage. Project History with links to source of information ...

Increase in higher risk prostate cancer cases following new screening recommendation by the US Preventive Services Task Force (USPSTF). This is an ASCO Meeting Abstract from the 2015 Genitourinary ...

Prostate cancer treatment has undergone a remarkable transformation over the past decade, with the integration of androgen ...

Figure 1. Time to castration-resistant prostate cancer (CRPC) by PSMA PET/CT bone lesion cohort at initial staging. Kaplan Meier curves showing time to CRPC by bone lesion cohort on PSMA PET/CT at ...

In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with 18 F-DCFPyL PSMA PET/CT has been shown to considerably improve detection of active disease as ...

For many women caring for a husband, partner, father or loved one with advanced prostate cancer, there comes a moment when the conversation suddenly becomes much more technical. The oncologist starts ...

A new UCLA Health Jonsson Comprehensive Cancer Center-led study has revealed that advanced prostate-specific membrane antigen positron emission tomography (PSMA-PET) imaging could reveal metastatic ...